Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Cronos Group Inc.TSX: CRON.TO

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin growth accelerates

Q1 FY2026 selling, general & admin of $18.46M rose 15.3% year over year, ahead of the -5.6% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 6.5% from the prior quarter. Over 3 fiscal years it compounded at -9.6% a year.

Context

  • Selling, general & admin amounted to 50.3% of revenue in FY2025, down 15.0 pp from a year earlier.
  • Selling, general & admin increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 4 analysts of $232.57M (+210.0%) for the fiscal year ending Dec 2026, a step up from the -2.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$18.46M-6.5% QoQ
Last fiscal yearDec 2025
$75.01M-2.3% YoY
LTMMar 2026
$72.37M-5.6% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.3%+162.6%+147.3 pp
1 year-2.3%+210.0%+212.3 pp
3-year CAGR-9.6%+60.8%+70.5 pp
5-year CAGR+33.7%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
75.01M USD
Year-over-year change
-2.3%
4-year CAGR
-11.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -5.6% is the lowest of 6, against a peer median of +29.4%.
  • Selling, general & admin amounts to 45.4% of revenue for CRON.TO, versus a peer median of 30.0%.
CRON.TO Competitors
Selling, General & Admin for CRON.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EXE.TOExtendicare Inc.LTM Jun 2026CA$1.26B CAD+34.4%+198.5%63.5%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$461.46M CAD+37.8%+24.5%31.3%
TLRY.TOTilray Brands, Inc.LTM Feb 2026$257.62M USD+0.5%+4.3%30.0%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$132.41M CAD+29.4%+11.8%25.9%
CRON.TOCronos Group Inc.LTM Mar 2026$72.37M USD-5.6%-9.6%45.4%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$45.24M CAD+19.2%+9.5%4.1%
Peer median (excluding CRON.TO) —+29.4%+11.8%30.0%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue64.02M87.54M87.03M117.5M149.15M
Cost of Revenue81.47M71.96M75.15M87.05M87.45M
Gross Profit(17.45M)15.58M11.88M30.45M61.7M
Gross Margin-27.3%17.8%13.7%25.9%41.4%
Research & Development21.66M13.25M5.83M4.22M4.53M
Selling, General & Admin120.67M101.64M80.74M76.74M75.01M
Operating Expenses272.09M128.01M96.48M106.91M79.54M
Depreciation & Amortization13.36M11.52M7.44M8.84M14.48M
EBITDA(150.79M)(93.81M)(72.28M)(45.37M)(2.94M)
EBITDA Margin-235.5%-107.2%-83.0%-38.6%-2.0%
Operating Income(289.54M)(112.44M)(84.6M)(76.46M)(17.84M)
Operating Margin-452.2%-128.4%-97.2%-65.1%-12.0%
Interest Income8.92M21.84M52.07M49.52M40.66M
Interest Expense00000
Other Income / Expenses162.1M(9.66M)11.1M113.01M419.21K
Income Before Tax(127.44M)(122.1M)(73.49M)36.55M(17.42M)
Pre-Tax Margin-199.1%-139.5%-84.4%31.1%-11.7%
Income Tax Expense(427.41K)34.48M(3.23M)(3.44M)(14.44M)
Net Income(392.81M)(170.26M)(73.79M)41.04M(9.61M)
Net Margin-613.5%-194.5%-84.8%34.9%-6.4%
EPS (Basic)(0.34)(0.42)(0.18)0.10(0.03)
EPS (Diluted)(0.34)(0.42)(0.18)0.10(0.03)
Weighted Avg Shares369.73M370.39M380.96M382.16M383.47M
Weighted Avg Shares (Diluted)370.39M370.39M380.96M382.16M383.47M

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.